Literature DB >> 12697422

Human RPE cell lysis of extracellular matrix: functional urokinase plasminogen activator receptor (uPAR), collagenase and elastase.

Susan G Elner1, Victor M Elner, Andrei L Kindzelskii, Kai Horino, Harry R Davis, Robert F Todd, Seymour Glagov, Howard R Petty.   

Abstract

Age-related macular degeneration (ARMD), proliferative vitreoretinopathy (PVR) and uveitis are characterized by RPE motility through the ECM of retinal lesions. The purpose of this study was to test the hypothesis that multiple proteolytic systems are functionally intact at the HRPE surface and peri-cellular region and that these activities are differentially modulated by IL-1beta. HRPE cells were evaluated: (1). as individual cells or cell extracts, (2). during migration across three-dimensional ECM-like layers and (3). in tissue sections. The urokirase plasminogen activator receptor (uPAR; CD87) was detected on HRPE cells as well as its functional activity. Although uPAR was associated with CD11b (CR3) on live resting cells, polarized migratory HRPE cells were found to dissociate uPAR from CR3; uPAR then translocated to anterior pole of the cell, where it enhanced PAI-1-inhibitable local proteolytic activity. The relative contribution of uPAR and collagenase in HRPE migration was evaluated using three-dimensional gelatin matrices. Interestingly, uPAR/uPA was found to play a key role in migration across these layers. IL-1 upregulated uPAR, collagenase, and elastase activities, suggesting that cytokines may affect the invasive program of HRPE cells in vivo. Immunohistochemistry for uPAR was performed in sections of human retina. Immunoreactive uPAR was present along the HRPE basolateral membrane in retinal sections and in sections of diseased retinal tissue at an enhanced level. Our results suggest that multiple proteolytic systems are present in association with HRPE and that the uPAR/uPA system may be particularly important.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12697422     DOI: 10.1016/s0014-4835(03)00028-9

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  10 in total

1.  The IL-1 type 1 receptor is required for the development of LPS-induced airways disease.

Authors:  David M Brass; John W Hollingsworth; Michael B Fessler; Jordan D Savov; Abby B Maxwell; Gregory S Whitehead; Lauranell H Burch; David A Schwartz
Journal:  J Allergy Clin Immunol       Date:  2007-05-18       Impact factor: 10.793

2.  TLR4 mediates human retinal pigment epithelial endotoxin binding and cytokine expression.

Authors:  Susan G Elner; Howard R Petty; Victor M Elner; Ayako Yoshida; Zong-Mei Bian; Dongli Yang; Andrei L Kindezelskii
Journal:  Trans Am Ophthalmol Soc       Date:  2005

3.  Increased soluble urokinase plasminogen activator receptor (suPAR) levels in neovascular age-related macular degeneration: a role for inflammation in the pathogenesis of the disease?

Authors:  Fabrizio Scotti; Paolo Milani; Marco Setaccioli; Silvia Maestroni; Nicolai Sidenius; Valentina De Lorenzi; Amedeo Massacesi; Fulvio Bergamini; Gianpaolo Zerbini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-01-07       Impact factor: 3.117

4.  Distinct CD40L receptors mediate inflammasome activation and secretion of IL-1β and MCP-1 in cultured human retinal pigment epithelial cells.

Authors:  Zong-Mei Bian; Matthew G Field; Susan G Elner; J Michelle Kahlenberg; Victor M Elner
Journal:  Exp Eye Res       Date:  2018-02-16       Impact factor: 3.467

5.  Inhibition of choroidal neovascularization in rats by the urokinase-derived peptide A6.

Authors:  Hyoung J Koh; Kenichiro Bessho; Lingyun Cheng; Dirk-Uwe Bartsch; Terence R Jones; Germain Bergeron-Lynn; William R Freeman
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-02       Impact factor: 4.799

6.  Diabetes-induced superoxide anion and breakdown of the blood-retinal barrier: role of the VEGF/uPAR pathway.

Authors:  Azza B El-Remessy; Telina Franklin; Nagla Ghaley; Jinling Yang; Michael W Brands; Ruth B Caldwell; Mohamed Ali Behzadian
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

Review 7.  EMT and EndMT: Emerging Roles in Age-Related Macular Degeneration.

Authors:  Daisy Y Shu; Erik Butcher; Magali Saint-Geniez
Journal:  Int J Mol Sci       Date:  2020-06-16       Impact factor: 5.923

Review 8.  Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD).

Authors:  Luis García-Onrubia; Fco Javier Valentín-Bravo; Rosa M Coco-Martin; Rogelio González-Sarmiento; J Carlos Pastor; Ricardo Usategui-Martín; Salvador Pastor-Idoate
Journal:  Int J Mol Sci       Date:  2020-08-18       Impact factor: 5.923

9.  Leukocyte Integrin Antagonists as a Novel Option to Treat Dry Age-Related Macular Degeneration.

Authors:  Monica Baiula; Alberto Caligiana; Andrea Bedini; Junwei Zhao; Federica Santino; Martina Cirillo; Luca Gentilucci; Daria Giacomini; Santi Spampinato
Journal:  Front Pharmacol       Date:  2021-01-29       Impact factor: 5.810

Review 10.  Age-related macular degeneration and changes in the extracellular matrix.

Authors:  Małgorzata Nita; Barbara Strzałka-Mrozik; Andrzej Grzybowski; Urszula Mazurek; Wanda Romaniuk
Journal:  Med Sci Monit       Date:  2014-06-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.